ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2,3,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
4,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
5,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
7,1,Bronchopleural fistula,Pleural conditions NEC,Pleural disorders,Resp,N
7,2,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
7,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
7,5,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
8,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
9,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
9,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
10,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
10,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
11,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
12,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
12,5,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
12,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
12,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
13,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
13,2,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
13,3,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
14,1,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
15,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
16,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
16,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
16,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
16,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
16,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
16,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
16,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
16,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
17,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
17,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
17,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,4,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
18,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
19,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
20,1,Biopsy liver abnormal,Hepatobiliary histopathology procedures,Hepatobiliary investigations,Inv,N
20,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
20,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
20,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
20,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
21,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
21,2,Lack of spontaneous speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
21,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
22,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
23,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
23,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
23,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
23,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
23,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
23,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
23,8,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
23,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
24,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
25,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
26,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
26,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
26,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
26,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
27,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
28,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
28,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
29,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
30,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
30,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
30,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
32,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
33,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
33,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
33,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
33,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
33,6,Psychological trauma,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
34,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
35,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
35,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
35,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
35,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
36,2,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
37,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
37,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
37,3,Diabetic hyperosmolar coma,Coma states,Neurological disorders NEC,Nerv,N
37,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
37,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
37,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
37,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
37,9,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
37,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
37,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
37,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
38,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
38,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
38,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
38,6,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
38,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
39,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
39,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
39,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
39,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
41,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
42,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
43,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
43,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
44,1,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
44,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
45,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
46,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
46,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
47,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
47,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
48,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
49,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
49,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
49,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
50,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
51,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
51,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
51,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
51,4,Pseudocyst,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,5,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
52,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
52,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
52,3,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
52,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
52,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
52,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
52,7,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
52,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
52,9,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
52,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
52,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
53,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
54,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
55,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
56,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
57,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
58,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
58,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
59,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
59,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
60,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
61,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
61,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
61,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
62,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
63,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
64,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
65,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
65,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
66,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
67,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
67,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
68,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,1,Breathing-related sleep disorder,Dyssomnias,Sleep disorders and disturbances,Psych,N
69,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
69,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
69,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
69,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
69,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
69,7,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
69,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
70,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
70,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
71,1,Breathing-related sleep disorder,Dyssomnias,Sleep disorders and disturbances,Psych,N
71,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
71,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
71,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
71,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
71,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
71,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
71,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
71,9,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
71,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
72,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
72,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
72,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
73,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
73,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
74,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
74,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
74,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
74,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
75,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
75,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
75,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
76,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
76,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
76,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
77,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
77,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
78,1,Cold agglutinins positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
78,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
78,3,Hodgkin's disease recurrent,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
78,4,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
79,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
79,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
80,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
80,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
81,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
82,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
82,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
83,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,Y
84,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
85,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
85,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
85,3,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
85,4,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
85,5,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
85,6,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
85,7,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
85,8,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
85,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
85,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
85,11,Myalgia,Muscle pains,Muscle disorders,Musc,N
85,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
85,13,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
86,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
87,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
87,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
87,3,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
88,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
89,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
92,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
92,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
92,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
92,6,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
92,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
92,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
92,9,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
93,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
94,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
95,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
95,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
96,1,Hodgkin's disease stage IV,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,Y
96,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
97,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
98,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
99,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
100,1,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
100,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,Y
101,1,Adrenocortical carcinoma,Adrenal neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
102,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
102,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
103,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
103,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
104,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
105,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
106,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
107,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
108,1,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
109,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
109,3,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
109,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
109,5,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
109,6,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
110,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
110,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
110,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
110,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
110,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
110,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
110,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
110,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
110,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
110,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
110,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
111,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
111,3,Therapeutic response delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
112,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
113,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
113,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
114,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
114,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
114,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
114,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
115,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
116,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
116,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
117,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
117,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
118,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
118,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
119,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
119,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
120,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
120,2,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
120,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
120,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
120,5,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
120,6,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
120,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
121,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
122,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
123,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
124,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
125,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,Y
126,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
127,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
127,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
127,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
128,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
129,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
130,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
130,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
130,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
131,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
132,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
132,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
134,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
135,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
135,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
136,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
136,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
136,3,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
136,4,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
136,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
137,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
138,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
139,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
139,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
139,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
140,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
140,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
140,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
141,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
141,2,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
141,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
142,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
143,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
144,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
144,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
144,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
144,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
145,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
145,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
146,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
147,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
147,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
148,2,Cutaneous T-cell lymphoma recurrent,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
148,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
148,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
148,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
149,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
150,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
150,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
150,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
150,4,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
150,5,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
151,1,Angioimmunoblastic T-cell lymphoma,Angioimmunoblastic T-cell lymphomas,Lymphomas non-Hodgkin's T-cell,Neopl,N
152,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
153,1,Deafness,Hearing losses,Hearing disorders,Ear,N
153,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
153,3,Headache,Headaches NEC,Headaches,Nerv,N
154,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
155,1,Hodgkin's disease recurrent,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
156,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
156,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
157,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
157,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
158,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
158,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
159,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
159,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
160,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
160,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
161,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
161,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
162,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
163,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
164,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
164,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
164,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
165,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
166,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
167,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
168,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
169,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
169,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
169,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
169,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
169,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
169,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
170,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
171,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
172,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
173,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
173,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
173,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
174,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
174,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
175,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
175,2,Cutaneous T-cell lymphoma recurrent,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
176,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
177,1,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
178,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
179,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
180,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
181,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
182,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
183,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
184,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
184,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
185,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
186,1,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
186,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
186,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
186,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
186,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
187,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
188,1,Natural killer-cell lymphoblastic lymphoma,Precursor T-lymphoblastic lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
188,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
189,1,Grey zone lymphoma,Lymphomas unclassifiable malignant,Lymphomas NEC,Neopl,N
189,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
190,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
190,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
190,3,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
190,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
190,5,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
191,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
191,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
191,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
191,4,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
192,1,Hodgkin's disease recurrent,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
193,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
193,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
193,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
193,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
194,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
194,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
194,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
195,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
195,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
195,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
196,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
197,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
197,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
198,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
199,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
199,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
199,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
199,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
200,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
200,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
200,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
200,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
200,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
200,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
201,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
201,2,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
201,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
201,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
201,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
201,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
201,7,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
201,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
201,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
202,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
202,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
202,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
202,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
202,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
202,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
203,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
203,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
203,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
203,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
203,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
203,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
203,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
204,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
204,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
205,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
205,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
